Knowledge Center

Patent / Aug 04, 2022

Inhaled ivermectin

Authors:
  • Beatriz Fernandes
  • João Henriques
  • Eunice Costa
  • Venkatesh Naini
Source:
US 20220241307

The present invention contemplates the use of inhaled ivermectin for use in various viruses and parasitic infections (treatment and/or prophylaxis) that are present or manifest in the lungs or respiratory tract. Exemplary dosing, formulations, devices, and processing techniques are also disclosed herein.
Ìý

Also in the Knowledge Center

Related Content

Sunriser® DPI

High Performance, High-Dose Capsule DPI.

Page
Read more

Inhalation grade particles

ËÄÉ«AV is a global expert in particle engineering, an essential technology when developing inhalation drug products.

Page
Read more

Management

ËÄÉ«AV is an independent family owned international group of companies.

Page
Read more